Sign in
4/A

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-005222

Chief Scientific Officer sold 100,000 shares at an average $67.60 ($6,759,576)

  • Chief Scientific Officer acquired 100,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2021-01-19 Option exercise +50,000 $6.55 $327,500 50,679 D
ROBINS HARLAN S Chief Scientific Officer 2021-01-19 Sale −31,146 $67.02 $2,087,405 19,533 D
ROBINS HARLAN S Chief Scientific Officer 2021-01-19 Sale −3,001 $67.74 $203,288 16,532 D
ROBINS HARLAN S Chief Scientific Officer 2021-01-19 Sale −5,701 $69.26 $394,851 10,831 D
ROBINS HARLAN S Chief Scientific Officer 2021-01-19 Sale −8,052 $69.97 $563,398 2,779 D
ROBINS HARLAN S Chief Scientific Officer 2021-01-19 Sale −2,100 $70.75 $148,575 679 D
ROBINS HARLAN S Chief Scientific Officer 2021-01-20 Option exercise +50,000 $6.55 $327,500 50,679 D
ROBINS HARLAN S Chief Scientific Officer 2021-01-20 Sale −20,394 $66.84 $1,363,135 30,285 D
ROBINS HARLAN S Chief Scientific Officer 2021-01-20 Sale −24,945 $67.39 $1,681,044 5,340 D
ROBINS HARLAN S Chief Scientific Officer 2021-01-20 Sale −4,661 $68.20 $317,880 679 D
Derivatives
ROBINS HARLAN S Chief Scientific Officer 2021-01-19 Option exercise · Stock Option (Right to Buy) −50,000 350,000 D
ROBINS HARLAN S Chief Scientific Officer 2021-01-20 Option exercise · Stock Option (Right to Buy) −50,000 300,000 D
Open-market sales · 100,000 sh · avg $67.60 · $6,759,576
Loading xslF345X03/doc4a.xml…